Physician

Abdullah Alshammaa, MD

According to 2025 Medicare claims, Abdullah Alshammaa, MD (NPI: 1073908869) practices neurology in the San Diego-Chula Vista-Carlsbad, CA market, with the plurality of this provider's patient population coming from San Diego, CA. This provider's primary affiliated billing organization is CEP AMERICA- NEUROLOGY, PC (NPI: 1073028569; TIN: 814978794) and primary practice location at 91911-6617. Alshammaa is affiliated with the POM ACO (ACO ID: A1297) and Mosaic ACO (ACO ID: A5033), participating under the MSSP model.

Alshammaa's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 258 traditional Medicare patients, billed 385 HCPCS/CPT codes, and received $34,195 in Medicare payments. The top billing code was 95720 (Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional). Part D data shows 469 prescription claims across 106 beneficiaries totaling $89,210 in drug costs, led by Briviact (Brivaracetam). Open Payments data shows 5 records totaling $118. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $4,856 to $89,210. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$37K$74K2020 Medicare payment: $19,993 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $74,469 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $59,685 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $36,794 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $34,195 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
202085215$19,993
2021398895$74,469
2022402697$59,685
2023238344$36,794
2024258385$34,195

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$45K$89K2015 Drug cost: $4,856 (USD; Tot_Drug_Cst)2016 Drug cost: $11,086 (USD; Tot_Drug_Cst)2017 Drug cost: $7,015 (USD; Tot_Drug_Cst)2018 Drug cost: $17,949 (USD; Tot_Drug_Cst)2019 Drug cost: $4,004 (USD; Tot_Drug_Cst)2020 Drug cost: $2,556 (USD; Tot_Drug_Cst)2021 Drug cost: $11,491 (USD; Tot_Drug_Cst)2022 Drug cost: $20,186 (USD; Tot_Drug_Cst)2023 Drug cost: $60,509 (USD; Tot_Drug_Cst)2024 Drug cost: $89,210 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152468$4,856
201661239$11,086
201753195$7,015
201861207$17,949
201930124$4,004
20201130$2,556
20212075$11,491
202227178$20,186
2023117457$60,509
2024106469$89,210

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
95720Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional3268$152
99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes5858$99
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more2222$63
95816Measurement of brain wave activity (eeg), awake and drowsy5152$43
95819Measurement of brain wave activity (eeg), awake and asleep2222$42

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
BriviactBrivaracetam15431$20,789
Emgality PenGalcanezumab-Gnlm22624$14,899
UbrelvyUbrogepant11235$10,798
LacosamideLacosamide311,278$1,278
Divalproex SodiumDivalproex Sodium12360$1,068

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.5$118UCB, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Abdullah Alshammaa, MD?

Tedicare shows public-source Medicare data for Abdullah Alshammaa, MD (NPI 1073908869), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abdullah Alshammaa, MD have ACO affiliation data?

Abdullah Alshammaa, MD is shown with ACO affiliation data for POM ACO (MSSP, ACO ID A1297) and Mosaic ACO (MSSP, ACO ID A5033).

What billing organization is linked to Abdullah Alshammaa, MD?

Abdullah Alshammaa, MD is linked to CEP AMERICA- NEUROLOGY, PC (billing NPI 1073028569) in the available physician profile data.

Does Abdullah Alshammaa, MD have Open Payments data?

Abdullah Alshammaa, MD has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.